TABLE 4.
Response of rosacea patients to treatment with topical timolol maleate 0.5%
| VARIABLES | BEFORE, n (%) | AFTER, n (%) | P-VALUE |
|---|---|---|---|
| Erythema | |||
| Absent | 0 (0) | 8 (13.8) | 0.09* |
| Mild | 18 (31) | 20 (34.5) | |
| Moderate | 40 (69) | 30 (51.7) | |
| Papules/pustules | |||
| Absent | 22 (37.9) | 28 (48.3) | 0.62* |
| Mild | 22 (37.9) | 22 (37.9) | |
| Moderate | 12 (20.7) | 8 (13.8) | |
| Severe | 2 (3.4) | 0 (0) | |
| Telangiectasia | |||
| Absent | 0 (0) | 6 (10.3) | 0.16* |
| Mild | 30 (51.7) | 32 (55.2) | |
| Moderate | 28 (48.3) | 20 (34.5) | |
| IGA | |||
| Almost clear | 0 (0) | 6 (10.4) | 0.09* |
| Mild | 10 (17.2) | 20 (34.5) | |
| Moderate | 32 (55.2) | 20 (34.5) | |
| Severe | 16 (27.6) | 12 (20.6) | |
*
Not significant (P>0.05)